2,561 results on '"Sueta A"'
Search Results
52. Edoxaban for 12 Versus 3 Months in Cancer-associated Isolated Distal Deep Vein Thrombosis According to Different Doses: Insights from the ONCO DVT study
53. Sistemas de alerta de tempestades elétricas: Um estudo de caso na Arena Pantanal
54. Cognitive Modeling Based on Perceiving-Acting Cycle in Robotic Avatar System for Disabled Patients.
55. Prognostic value of left atrial strain in patients with wild‐type transthyretin amyloid cardiomyopathy
56. Prognostic significance of liver stiffness assessed by fibrosis‐4 index in patients with heart failure
57. Time-dependent change of relative apical longitudinal strain index in patients with wild-type transthyretin amyloid cardiomyopathy
58. Socioeconomic status and modification of atherosclerotic cardiovascular disease risk prediction: epidemiological analysis using data from the atherosclerosis risk in communities study
59. Validation of the Khorana Venous Thromboembolism Risk Score in Japanese Cancer Patients
60. Chemical basis of cysteine reactivity and specificity: Acidity and nucleophilicity
61. Contributors
62. Validation of the Khorana Venous Thromboembolism Risk Score in Japanese Cancer Patients
63. External validation of the Pulmonary Embolism-Syncope, Anemia, and Renal Dysfunction bleeding score for early major bleeding in patients with acute pulmonary embolism: from the COMMAND VTE Registry-2
64. Clinical significance of reactive oxidative metabolites in patients with heart failure with reduced left ventricular ejection fraction
65. Abstract 12648: Comparison of Transthyretin Amyloid Cardiomyopathy Patients Taking Tafamidis and Those Not Taking Tafamidis Using Two-Dimensional Speckle Tracking Echocardiography
66. Abstract 12457: Usefulness of Automatic Assessment for Longitudinal Strain to Diagnose Wild-Type Transthyretin Amyloid Cardiomyopathy
67. Abstract 11849: The Influence of Atrial Fibrillation on Mortality Among Cancer Patients
68. Abstract 11434: Soluble Programed Cell Death Ligand-1 is Associated With Future Heart Failure Hospitalization in Patients With Atherosclerotic Cardiovascular Disease
69. Analysis of plasma HER2 copy number in cell-free DNA of breast cancer patients: a comparison with HER2 extracellular domain protein level in serum
70. The evaluation of the safety and efficacy of intravenously administered allogeneic multilineage-differentiating stress-enduring cells in a swine hepatectomy model
71. Rendering of Virtual Walking Sensation by a Vestibular Display.
72. Rendering of Virtual Walking Sensation by a Vestibular Display
73. Venous thrombosis in evacuees during war: Will the experience of our ancestors be put to good use?
74. The usefulness of C-reactive protein to predict improving left ventricular function after aortic valve replacement in patients with aortic regurgitation
75. The controlling nutritional status score predicts outcomes of cardiovascular events in patients with heart failure with preserved ejection fraction
76. Cytotoxin-associated gene-A-seropositivity and Interleukin-1 polymorphisms influence adverse cardiovascular events
77. Open-Label, Single-Center, Single-Arm Study Evaluating the Efficacy and Safety of Elobixibat for Chronic Constipation in Patients With Heart Failure
78. A new staging system using right atrial strain in patients with immunoglobulin light‐chain cardiac amyloidosis
79. Correlation Between C-Reactive Protein (CRP) Level and Chemotherapy Response in Colorectal Cancer Patients Based on Carcinoembryonic Antigen (CEA) Levels in Post Definitive Operative and Adjuvant Chemotherapy Three Series at Prof. Dr. I.G.N.G Ngoerah Denpasar Hospital
80. Neoplastic fibrocytes play an essential role in bone marrow fibrosis in Jak2V617F-induced primary myelofibrosis mice
81. Clinical characteristics and natural history of wild‐type transthyretin amyloid cardiomyopathy in Japan
82. Left‐dominant arrhythmogenic cardiomyopathy with a nonsense mutation in DSP
83. H2FPEF score for predicting future heart failure in stable outpatients with cardiovascular risk factors
84. Cardiac computed tomography-derived extracellular volume fraction in late anthracycline-induced cardiotoxicity
85. Lenvatinib, an oral multi-kinases inhibitor, -associated hypertension: Potential role of vascular endothelial dysfunction
86. Prevalence of extracardiac findings in patients undergoing coronary computed tomography and additional low-dose whole-body computed tomography
87. CABG Improves Outcomes in Patients With Ischemic Cardiomyopathy: 10-Year Follow-Up of the STICH Trial
88. Reduction in thrombogenic activity and thrombocytopenia after transcatheter aortic valve implantation — The ATTRACTIVE-TTAS study
89. Improvement of Vascular Endothelial Function Reflects Nonrecurrence After Catheter Ablation for Atrial Fibrillation
90. Clinical outcomes of catheter ablation for atrial fibrillation, atrial flutter, and atrial tachycardia in wild-type transthyretin amyloid cardiomyopathy: a proposed treatment strategy for catheter ablation in each arrhythmia.
91. An autopsy case of an adult woman with Rapid-Onset Obesity with Hypoventilation, Hypothalamic, Autonomic Dysregulation, and Neuroendocrine Tumors (ROHHAD(NET)) syndrome developing nonalcoholic steatohepatitis and hepatocellular carcinoma: A case report.
92. Associations of cardiovascular risk factors with survival outcomes in a cancer registration: Findings from the KUMAMON registry
93. Kinetic and structural assessment of the reduction of human 2‐Cys peroxiredoxins by thioredoxins
94. A Predictive Model for Cancer-Associated Thrombosis in Japanese Cancer Patients: Findings from the J-Khorana Registry
95. Efficacy of sodium-glucose cotransporter 2 inhibitors on cardiorenal outcomes in older patients: a systematic review and meta-analysis
96. Sex differences for the efficacy of sodium-glucose cotransporter 2 inhibitors on cardiorenal outcomes: a systematic review and meta-analysis
97. An Incisive Look at the Reduction of 2Cys Peroxiredoxins by Thioredoxins
98. Characterization of a fluorescent biosensor with specificity for organic peroxides
99. Role of Imidazole and Chelate Ring Size in Copper Oxidation Catalysts: An Experimental and Theoretical Study
100. Cross-sections and analyzing powers for $(p,n)$ reactions on ${}^{3}{\rm He}$ and ${}^{4}{\rm He}$ at 346 MeV
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.